'reduced visibility'....interesting take. http://www.streetinsider.com/Analys...e Corporation (UNIS) to Neutral/11419455.html
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%